Radiation Oncology Market Trends: Hypofractionation, Adaptive Therapy & Patient-Centred Care
Major trends in the Radiation Oncology Market include hypofractionated regimens, adaptive therapy workflows and enhanced patient-centred care designs. Hypofractionation—delivering higher dose in fewer sessions—optimizes resources, improves patient convenience and increases
throughput. Adaptive therapy adapts radiation plans in real-time based on tumour and organ-motion changes, enabled by advanced imaging and AI-planning algorithms. Patients benefit from shortened treatment times, reduced side-effects and improved comfort.
Patient-centred care design also influences centre build-outs and equipment preference—compact linac footprints, faster beam-on times, integrated imaging and better immobilisation devices. Immersive patient-experience elements, like audio-visual systems, accelerated workflow, and outpatient treatment chairs rather than beds, reflect the shift towards convenience and comfort. Together, these trends reshape treatment delivery and investment decisions across the radiation oncology market.
FAQs
What is hypofractionation? Treatment delivered in fewer, larger doses.
What is adaptive therapy? Radiation plan adjusted in real-time to patient anatomy.
What drives patient focus? Shorter visits, less disruption and improved comfort.